Detalles de la búsqueda
1.
Chemical biology fluorescent tools for in vitro investigation of the multidrug resistant P-glycoprotein (P-gp) expression in tumor cells.
RSC Adv
; 13(39): 27016-27035, 2023 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693089
2.
The New Serum-Free OptiPASS® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.
Cancers (Basel)
; 13(8)2021 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33919619
3.
LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models.
Cancers (Basel)
; 13(16)2021 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439204
4.
The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.
J Clin Med
; 8(3)2019 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30901969
5.
Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy.
J Clin Med
; 9(1)2019 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31888054
6.
Development and validation of a high-performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells.
J Pharm Biomed Anal
; 152: 74-80, 2018 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29414021
7.
Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.
Oncotarget
; 8(56): 95316-95331, 2017 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29221130
Resultados
1 -
7
de 7
1
Próxima >
>>